DNAhsp65 vaccine: state of the art (2006)
- Authors:
- USP affiliated authors: SILVA, CELIO LOPES - FMRP ; CASTELO, ARLETE A. M. C. - FMRP ; FACCIOLI, LUCIA HELENA - FCFRP
- Unidades: FMRP; FCFRP
- Subjects: VACINAS; GENÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: INTERCELL Meeting Management
-
ABNT
SILVA, Célio Lopes et al. DNAhsp65 vaccine: state of the art. 2006, Anais.. Viena: INTERCELL, 2006. . Acesso em: 01 out. 2024. -
APA
Silva, C. L., Bonato, V. L. D., Coelho-Castelo, A. A. M., Faccioli, L. H., Sartori, A., & Lopes, H. F. (2006). DNAhsp65 vaccine: state of the art. In Abstracts. Viena: INTERCELL. -
NLM
Silva CL, Bonato VLD, Coelho-Castelo AAM, Faccioli LH, Sartori A, Lopes HF. DNAhsp65 vaccine: state of the art. Abstracts. 2006 ;[citado 2024 out. 01 ] -
Vancouver
Silva CL, Bonato VLD, Coelho-Castelo AAM, Faccioli LH, Sartori A, Lopes HF. DNAhsp65 vaccine: state of the art. Abstracts. 2006 ;[citado 2024 out. 01 ] - HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis
- Evaluation of immune response and protection against tuberculosis using DNA-hsp65 vaccine delivery by liposomes
- Hsp65-DNA vaccine (pVAX-hsp65) stimulates cytokine production by human macrophages
- Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis
- Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis
- Lipossomas catiônicas como carreadores de vacina de DNA contra a tuberculose
- Therapeutic effect of DNA-HSP65 vaccine against Mycobacterium tuberculosis in mice coinfected with Toxocara canis
- "Prime-Boost" strategy using BCG and DNA-hsp65 induces Th1 pattern in murine model
- MRNA-HSP65 binding toll 7 and protects mice against experimental tuberculosis
- Evaluation of immune response and protection against tuberculosis using DNA-hsp65 vaccine delivery by liposomes
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas